#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16106	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2021	791.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	966	C	893	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16106	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2021	791.1	0	HET	.	.	.	C207T	.	207	207	C	433	433	C	885	C,T	640,186	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16106	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2021	791.1	0	HET	.	.	.	C451T	.	451	451	C	677	677	C	945	C,T	671,217	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28458	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3553	798.5	0	.	n	.	0	T695C	SNP	695	695	T	1032	1032	C	876	C,T	819,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28458	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3553	798.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2308	2308	C	937	C	870	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28458	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3553	798.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2382	2382	A	956	A,G	903,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28458	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3553	798.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2934	2934	C	907	C	855	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28458	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3553	798.5	0	HET	.	.	.	A1638G	.	1638	1638	A	1975	1975	A	917	A,G	679,174	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2200	folP	855	855	100.0	folP.l6.c4.ctg.1	1494	146.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1021	1023	AGC	210;210;210	A;G;C	194;196;195	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5772	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3330	172.8	1	SNP	p	S91F	1	.	.	271	273	TTC	589	591	TTC	194;194;190	T;T;C	186;186;182	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5772	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3330	172.8	1	SNP	p	G95N	0	.	.	283	285	GGC	601	603	GGC	185;187;190	G;G;C	180;181;185	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5772	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3330	172.8	1	SNP	p	D95G	1	.	.	283	285	GGC	601	603	GGC	185;187;190	G;G;C	180;181;185	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1880	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1287	145.6	1	SNP	p	G45D	0	.	.	133	135	GGC	482	484	GGC	237;238;238	G;G;C	218;220;219	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	946	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	959	97.8	0	.	n	.	0	A197.	DEL	197	197	A	509	509	A	240	A	222	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2841	211.4	1	SNP	p	D86N	0	.	.	256	258	GAC	509	511	GAC	227;230;231	G;A;C	210;202;216	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2841	211.4	1	SNP	p	R87W	0	.	.	259	261	CGT	512	514	CGT	235;230;231	C;G;T	219;215;214	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2841	211.4	1	SNP	p	R87I	0	.	.	259	261	CGT	512	514	CGT	235;230;231	C;G;T	219;215;214	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2841	211.4	1	SNP	p	S87R	1	.	.	259	261	CGT	512	514	CGT	235;230;231	C;G;T	219;215;214	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2841	211.4	1	SNP	p	S88P	0	.	.	262	264	TCC	515	517	TCC	232;229;230	T;C;C	214;212;216	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4552	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2831	160.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1641	1643	GGC	212;209;209	G;G;C	190;186;189	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1205	1207	GCC	231;232;232	G;C;C	215;217;216	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1208	1210	ATG	233;235;240	A;T;G	220;223;226	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1220	1222	ACC	238;234;232	A;C;C	221;217;217	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1220	1222	ACC	238;234;232	A;C;C	221;217;217	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1721	1723	ACC	202;203;205	A;C;C,G	186;187;188,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1775	1777	GCG	214;214;221	G;C;G	196;196;203	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1775	1777	GCG	214;214;221	G;C;G	196;196;203	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1898	1900	GGT	178;177;175	G;G;T	163;162;159	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1907	1909	AGC	172;170;170	A;G,T;C	156;154,1;155	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4278	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2331	182.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1925	1927	CCG	147;149;144	C,G;C,G;G	114,3;116,1;110	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6356	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3027	209.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1569	1571	CCG	223;224;221	C;C;G	198;204;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2940	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1897	154.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	669	669	C	210	C	189	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3042	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1635	184.9	0	.	p	.	0	N214del	DEL	640	640	A	924	924	T	260	T	244	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3042	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1635	184.9	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1036	1038	GAA	251;251;250	G;A,G;A	235;230,1;229	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3042	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1635	184.9	0	.	p	.	0	G321S	NONSYN	961	963	GGC	1243	1245	AGC	230;230;233	A,G;G;C	211,1;214;217	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3042	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1635	184.9	1	SNP	p	G120K	1	.	.	358	360	AAG	643	645	AAG	250;250;249	A;A;G	234;235;230	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3042	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1635	184.9	1	SNP	p	N121D	0	.	.	361	363	AAC	646	648	AAC	252;254;254	A,G;A;C	234,1;241;239	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3042	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1635	184.9	1	SNP	p	A121N	1	.	.	361	363	AAC	646	648	AAC	252;254;254	A,G;A;C	234,1;241;239	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11122	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4808	230.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1172	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1043	111.8	1	SNP	p	V57M	1	.	.	169	171	ATG	475	477	ATG	233;233;233	A;T;G	223;223;223	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
